These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16332595)

  • 1. The potential of proton beam radiation therapy in head and neck cancer.
    Ask A; Björk-Eriksson T; Zackrisson B; Blomquist E; Glimelius B
    Acta Oncol; 2005; 44(8):876-80. PubMed ID: 16332595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of proton beam radiation therapy in breast cancer.
    Björk-Eriksson T; Glimelius B
    Acta Oncol; 2005; 44(8):884-9. PubMed ID: 16332597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of proton beam therapy in paediatric cancer.
    Björk-Eriksson T; Glimelius B
    Acta Oncol; 2005; 44(8):871-5. PubMed ID: 16332594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of proton beam radiation therapy in lung cancer (including mesothelioma).
    Bjelkengren G; Glimelius B
    Acta Oncol; 2005; 44(8):881-3. PubMed ID: 16332596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers.
    Johansson B; Ridderheim M; Glimelius B
    Acta Oncol; 2005; 44(8):890-5. PubMed ID: 16332598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of proton beam radiation therapy in gastrointestinal cancer.
    Ask A; Johansson B; Glimelius B
    Acta Oncol; 2005; 44(8):896-903. PubMed ID: 16332599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of proton beam radiation for palliation and reirradiation.
    Björk-Eriksson T; Ask A; Glimelius B
    Acta Oncol; 2005; 44(8):918-20. PubMed ID: 16332602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma.
    Björk-Eriksson T; Bjelkengren G; Glimelius B
    Acta Oncol; 2005; 44(8):913-7. PubMed ID: 16332601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number of patients potentially eligible for proton therapy.
    Glimelius B; Ask A; Bjelkengren G; Björk-Eriksson T; Blomquist E; Johansson B; Karlsson M; Zackrisson B
    Acta Oncol; 2005; 44(8):836-49. PubMed ID: 16332591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of proton beam radiation therapy in intracranial and ocular tumours.
    Blomquist E; Bjelkengren G; Glimelius B
    Acta Oncol; 2005; 44(8):862-70. PubMed ID: 16332593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton therapy of cancer: potential clinical advantages and cost-effectiveness.
    Lundkvist J; Ekman M; Ericsson SR; Jönsson B; Glimelius B
    Acta Oncol; 2005; 44(8):850-61. PubMed ID: 16332592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton radiation therapy for head and neck cancer.
    Chan AW; Liebsch NJ
    J Surg Oncol; 2008 Jun; 97(8):697-700. PubMed ID: 18493920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implementation of full Monte Carlo dose calculation in proton beam therapy.
    Paganetti H; Jiang H; Parodi K; Slopsema R; Engelsman M
    Phys Med Biol; 2008 Sep; 53(17):4825-53. PubMed ID: 18701772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.
    Peeters A; Grutters JP; Pijls-Johannesma M; Reimoser S; De Ruysscher D; Severens JL; Joore MA; Lambin P
    Radiother Oncol; 2010 Apr; 95(1):45-53. PubMed ID: 20106540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
    Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
    J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heavy charged particle radiotherapy--proton beam].
    Ogino T
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2030-5. PubMed ID: 14712761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy.
    Frese MC; Wilkens JJ; Huber PE; Jensen AD; Oelfke U; Taheri-Kadkhoda Z
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):80-8. PubMed ID: 20382482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.